Directorate Change

RNS Number : 0320R
Iconic Labs PLC
03 March 2021
 

 

3 March 2021

 

Iconic Labs Plc

("Iconic Labs", the "Company")

 

Board Changes

 

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, is pleased to announce the following proposed changes to the Board.

Brendan O' Mahony will be joining the board as a Non-Executive Director. Brendan is a certified accountant (FCCA) and previous partner at EY Poland where he led and grew the Poland and CEE focussed transaction advisory team. He currently holds a number of different private sector advisory and board roles across industries such as software development and tech.   

Willem van der Meer will also be joining the board as a Non-Executive Director. Willem an experienced investment banker and founder of AEK . Willem is founder and CEO of Micro Algae Inc, a Canadian based company specialized in Micro Algae. He has held a number of senior advisory positions specializing in mergers and acquisitions.

Also joining the board as a Non-Executive Director is David Štybr an experienced finance, banking and business development specialist. David is currently CEO of a Prague based family office. He holds a Master's degree in Economics.

All appointments are subject to regulatory checks

 

Sarah Dees, Chief Executive Officer, commented:

I am delighted to welcome Brendan, Willem and David to the board. They bring a wealth of experience across a variety of different sectors and I look forward to working with them to identify value accretive opportunities for the Company and its shareholders.

 

 

For further information, please visit the Company's website www.iconiclabs.co.uk

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSUFSDEFSELD

Companies

Iconic Labs (ICON)
UK 100

Latest directors dealings